Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jacobsen

Showing results (481-490 of 488) with videos related to

Pageof 49
Sort By:
You have reached the last page of results.This site can display upto 488 results.
FEMS Microbiology Reviews|November 24, 2020
The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectivesChristophe d'Enfert, Ann-Kristin Kaune, Leovigildo-Rey Alaban, et al.
JAMA|August 8, 2023
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical TrialTomas G Neilan, Thiago Quinaglia, Takeshi Onoue, et al.
The New England Journal of Medicine|December 12, 2017
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaSattva S Neelapu, Frederick L Locke, Nancy L Bartlett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2024
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma SubtypesBimarzhan Assatova, Robert Willim, Christopher Trevisani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell TransplantationAlex F Herrera, Matthew Mei, Lawrence Low, et al.
Nature Communications|May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
Cancer Cell|April 13, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.
Cancer Cell|August 2, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.
Pageof 49

Showing results (481-490 of 488) with videos related to

Sort By:
Pageof 49
You have reached the last page of results.This site can display upto 488 results.
FEMS Microbiology Reviews|November 24, 2020
The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectivesChristophe d'Enfert, Ann-Kristin Kaune, Leovigildo-Rey Alaban, et al.
JAMA|August 8, 2023
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical TrialTomas G Neilan, Thiago Quinaglia, Takeshi Onoue, et al.
The New England Journal of Medicine|December 12, 2017
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaSattva S Neelapu, Frederick L Locke, Nancy L Bartlett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2024
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma SubtypesBimarzhan Assatova, Robert Willim, Christopher Trevisani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2016
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell TransplantationAlex F Herrera, Matthew Mei, Lawrence Low, et al.
Nature Communications|May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
Cancer Cell|April 13, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.
Cancer Cell|August 2, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.
Pageof 49